<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>52(2)</volume><submitter>Spinicci M</submitter><pubmed_abstract>A late presenter AIDS patient with severe T cell depletion presented non-severe COVID-19 symptoms, with prolonged viral shedding. Our case report supports the hypothesis that an effective T cell response may be dispensable for the control of COVID-19 progression to severe forms, while it may be necessary for SARS-CoV-2 clearance.</pubmed_abstract><journal>European journal of immunology</journal><pagination>352-355</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9015404</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection.</pubmed_title><pmcid>PMC9015404</pmcid><pubmed_authors>Coppi M</pubmed_authors><pubmed_authors>Saccardi R</pubmed_authors><pubmed_authors>Rossolini GM</pubmed_authors><pubmed_authors>Mazzoni A</pubmed_authors><pubmed_authors>Botta A</pubmed_authors><pubmed_authors>Borchi B</pubmed_authors><pubmed_authors>Bartalesi F</pubmed_authors><pubmed_authors>Annunziato F</pubmed_authors><pubmed_authors>Giovacchini N</pubmed_authors><pubmed_authors>Bartoloni A</pubmed_authors><pubmed_authors>Spinicci M</pubmed_authors><pubmed_authors>Pieralli F</pubmed_authors><pubmed_authors>Graziani L</pubmed_authors><pubmed_authors>Mazzetti M</pubmed_authors><pubmed_authors>Colao MG</pubmed_authors><pubmed_authors>Tilli M</pubmed_authors></additional><is_claimable>false</is_claimable><name>AIDS patient with severe T cell depletion achieved control but not clearance of SARS-CoV-2 infection.</name><description>A late presenter AIDS patient with severe T cell depletion presented non-severe COVID-19 symptoms, with prolonged viral shedding. Our case report supports the hypothesis that an effective T cell response may be dispensable for the control of COVID-19 progression to severe forms, while it may be necessary for SARS-CoV-2 clearance.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-04T12:45:26.749Z</modification><creation>2024-11-09T10:37:06.689Z</creation></dates><accession>S-EPMC9015404</accession><cross_references><pubmed>34822185</pubmed><doi>10.1002/eji.202149574</doi></cross_references></HashMap>